Default company panoramic image

VueKlar Cardiovascular

Addressing the life-threatening and expensive complications associated with x-ray-based imaging, a need unmet by all competing products.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Dundee, Scotland, GB
  • Currency GBP
  • Founded August 2010
  • Employees 3
  • Website

Company Summary

Around 30% of all patients receiving cardiovascular implants (stents, filters, heart valves etc) are at substantial risk of contrast-induced nephropathy, a condition associated with high rates of mortality and morbidity, and significant, additional treatment costs. VueKlar is developing implants that avoid these risks, and simultaneously avoid patient exposure to cancer-causing, ionising radiation.